RE: Broker: Strong Financial Performance and Strategic Advancements Justify Buy Rating29 Apr 2025 10:39
Hello ex sparky.yes i am. it still is a p/e company ,although it now also owns deep longevity inc,an ageing clock longevity focussed ai company. regent has recently submitted its formal application to the chinese medical authority for approval of senstend`(the chines name for fortacin)and is hoping for approval by year end(although this is probably a tad optimistic). there is also a refinancing share issue exercise going on.,after which mellon and his pet companies will own just under 70% of the company,sosvery small pi free float. no one has any idea why its shooting up, although speculation is that it is in anticipation of chinese approval, but as that is months away at best, i'm not convinces. this is a potted version.you need to read the old plethora board(its still going on here)and read the regent announcements to see the long history.this is not a buy recommendation in any sense. most long term investors are massively under water. hope this helps a bit.